BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR OX40

The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which bind to OX40. The invention also relates to multimeric bi...

Full description

Saved in:
Bibliographic Details
Main Authors HARRISON, Helen, MCDONNELL, Kevin, STEPHEN, Tom Li, CHE, Harvey, KEEN, Nicholas, SKYNNER, Michael, CHEN, Liuhong, PARK, Peter
Format Patent
LanguageEnglish
French
German
Published 16.03.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which bind to OX40. The invention also relates to multimeric binding complexes of polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold that are functional agonists of OX40. The invention also includes drug conjugates comprising said peptides and complexes, conjugated to one or more effector and/or functional groups, to pharmaceutical compositions comprising said peptide ligands, complexes and drug conjugates and to the use of said peptide ligands and drug conjugates in preventing, suppressing or treating a disease or disorder mediated by OX40.
Bibliography:Application Number: EP20200728128